Bayer Reports That As Of April 8, 2014 Settlement Negotiations Have Resolved “approximately 8,560 claimants in the U.S. for a total amount of about US$1.74 billion”
SUMMARY: As of early April 2014 there were about 2000 unresolved YAZ / Yasmin / Ocella / Gianvi claims according to the Bayer Stockholders’ Newsletter First Quarter 2014.
Our previous article about this litigation was “YAZ / Yasmin Products Liability Litigation: February 2014 Bayer Information About The Number Of Claims, Lawsuits, And Settlements”, which included Bayer’s report that as of February 10, 2014 venous clot injuries (deep vein thrombosis or pulmonary embolism) were alleged by about 1,950 of the pending unsettled claimants.
The litigation update article before that was titled “During 2013 Bayer Has Had More Than 2000 YAZ / Yasmin Lawsuits For Blood Clots That Are Not Settled”.
In re-reading those articles again, now, it seems that Bayer’s settlement efforts have slowed down over the past year, for whatever reason(s).
[Read this article in full at original source]